{"id":352261,"date":"2025-08-26T07:28:15","date_gmt":"2025-08-26T07:28:15","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/how-to-buy-arcturus-therapeutics-holdings\/"},"modified":"2025-08-26T07:28:15","modified_gmt":"2025-08-26T07:28:15","slug":"how-to-buy-arcturus-therapeutics-holdings","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-arcturus-therapeutics-holdings\/","title":{"rendered":"Arcturus Therapeutics Holdings Inc. (ARCT) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Arcturus Therapeutics Holdings Inc. (ARCT) Hisse Senedi Yat\u0131r\u0131m\u0131"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334090,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-352261","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"Arcturus Therapeutics Holdings Inc. (ARCT) Hisseleri Nas\u0131l Al\u0131n\u0131r - Arcturus Therapeutics Holdings Inc. (ARCT) Hisse Senedi Yat\u0131r\u0131m\u0131","h1_source":{"label":"H1","type":"text","formatted_value":"Arcturus Therapeutics Holdings Inc. (ARCT) Hisseleri Nas\u0131l Al\u0131n\u0131r - Arcturus Therapeutics Holdings Inc. (ARCT) Hisse Senedi Yat\u0131r\u0131m\u0131"},"description":"Arcturus Therapeutics Holdings Inc. (ARCT) hisselerinin nas\u0131l al\u0131naca\u011f\u0131n\u0131 \u00f6\u011frenin ve bu umut vadeden biyotek hisse senedinde bilin\u00e7li yat\u0131r\u0131m kararlar\u0131 verin; kapsaml\u0131 analizimizle.","description_source":{"label":"Description","type":"textarea","formatted_value":"Arcturus Therapeutics Holdings Inc. (ARCT) hisselerinin nas\u0131l al\u0131naca\u011f\u0131n\u0131 \u00f6\u011frenin ve bu umut vadeden biyotek hisse senedinde bilin\u00e7li yat\u0131r\u0131m kararlar\u0131 verin; kapsaml\u0131 analizimizle."},"intro":"mRNA terap\u00f6tikleri alan\u0131nda yat\u0131r\u0131m yapmay\u0131 m\u0131 d\u00fc\u015f\u00fcn\u00fcyorsunuz? Arcturus Therapeutics (ARCT), \u015fu anda biyoteknoloji alan\u0131ndaki en heyecan verici f\u0131rsatlardan birini temsil ediyor. \u00c7\u0131\u011f\u0131r a\u00e7an a\u015f\u0131 teknolojisi ve ilerleyen bir\u00e7ok klinik programla, bu \u015firket size \u00f6nemli getiriler sa\u011flayabilir. ARCT hisselerine ilk yat\u0131r\u0131m\u0131n\u0131z\u0131 yaparken bilmeniz gereken her \u015feyi detayl\u0131ca a\u00e7\u0131klayaca\u011f\u0131z.","intro_source":{"label":"Intro","type":"text","formatted_value":"mRNA terap\u00f6tikleri alan\u0131nda yat\u0131r\u0131m yapmay\u0131 m\u0131 d\u00fc\u015f\u00fcn\u00fcyorsunuz? Arcturus Therapeutics (ARCT), \u015fu anda biyoteknoloji alan\u0131ndaki en heyecan verici f\u0131rsatlardan birini temsil ediyor. \u00c7\u0131\u011f\u0131r a\u00e7an a\u015f\u0131 teknolojisi ve ilerleyen bir\u00e7ok klinik programla, bu \u015firket size \u00f6nemli getiriler sa\u011flayabilir. ARCT hisselerine ilk yat\u0131r\u0131m\u0131n\u0131z\u0131 yaparken bilmeniz gereken her \u015feyi detayl\u0131ca a\u00e7\u0131klayaca\u011f\u0131z."},"body_html":"<h2>\ud83d\udcc8 G\u00fcncel Hisse Performans\u0131 ve \u00d6nemli Tarihler<\/h2> <p>26 A\u011fustos 2025 itibar\u0131yla, Arcturus Therapeutics Holdings Inc. (ARCT) NASDAQ borsas\u0131nda <strong>17,71 $<\/strong> fiyatla i\u015flem g\u00f6r\u00fcyor. Bu fiyat, \u015firketin son geli\u015fmeleri ve gelecekteki potansiyeli g\u00f6z \u00f6n\u00fcne al\u0131nd\u0131\u011f\u0131nda ilgi \u00e7ekici bir giri\u015f noktas\u0131 sunuyor.<\/p> <p><strong>Takviminize not edin: 6 Kas\u0131m 2025 kesinlikle kritik.<\/strong> Bu tarihte Arcturus, 3. \u00e7eyrek kazan\u00e7 raporunu a\u00e7\u0131klayacak. Tarihsel olarak, bu \u00e7eyreklik g\u00fcncellemeler \u00f6nemli fiyat hareketlerine neden olmu\u015f ve yat\u0131r\u0131m tezinizin kaderini belirleyebilir.<\/p> <h3>Kazan\u00e7 Raporlar\u0131 ARCT Hissesini Nas\u0131l Hareket Ettirir<\/h3> <p>Son tarihleri incelemek zamanlaman\u0131n neden \u00f6nemli oldu\u011funu g\u00f6steriyor:<\/p> <p><strong>\u015eubat 2025 4. \u00c7eyrek Kazan\u00e7lar\u0131<\/strong>: Hisse, olumlu klinik deneme g\u00fcncellemeleri sonras\u0131 %15 y\u00fckseldi; finansal sonu\u00e7lar kar\u0131\u015f\u0131k olsa da yat\u0131r\u0131mc\u0131lar k\u0131sa vadeli gelir d\u00fc\u015f\u00fc\u015flerinden \u00e7ok \u00fcr\u00fcn hatt\u0131ndaki ilerlemeye odakland\u0131.<\/p> <p><strong>A\u011fustos 2025 2. \u00c7eyrek Kazan\u00e7lar\u0131<\/strong>: Hisseler ba\u015flang\u0131\u00e7ta gelir endi\u015feleriyle %8 d\u00fc\u015ft\u00fc ancak analistlerin 2028'e kadar uzayan nakit runway'i vurgulamas\u0131yla birka\u00e7 g\u00fcn i\u00e7inde toparland\u0131.<\/p> <p><strong>May\u0131s 2025 Kurumsal G\u00fcncelleme<\/strong>: Grip a\u015f\u0131 adaylar\u0131 i\u00e7in FDA Fast Track tan\u0131m\u0131 duyurusu sonras\u0131 %22 art\u0131\u015f ya\u015fand\u0131.<\/p> <p>Desen a\u00e7\u0131k: ARCT, hem finansal sonu\u00e7lara hem de klinik\/d\u00fczenleyici haberlere dramatik \u015fekilde tepki veriyor. Ak\u0131ll\u0131 yat\u0131r\u0131mc\u0131lar, kazan\u00e7 sonras\u0131 d\u00fc\u015f\u00fc\u015fleri pozisyon a\u00e7mak i\u00e7in f\u0131rsat olarak izliyor.<\/p> [cta_green text=\"Ticarete Ba\u015fla\"]<h2>\ud83d\udcca 6 Ayl\u0131k Fiyat Yolculu\u011fu: Ama\u00e7l\u0131 Bir Rollercoaster<\/h2> <p>Arcturus hisseleri son alt\u0131 ayda \u00e7\u0131lg\u0131n ama nihayetinde \u00f6d\u00fcllendirici bir seyir izledi:<\/p> <ul> <li><strong>\u015eubat 2025<\/strong>: 12,50 $ (tatil sonras\u0131 konsolidasyon)<\/li> <li><strong>Mart 2025<\/strong>: 14,80 $ (KOSTAIVE COVID a\u015f\u0131s\u0131n\u0131n Avrupa onay\u0131)<\/li> <li><strong>May\u0131s 2025<\/strong>: 16,25 $ (FDA Fast Track tan\u0131m\u0131 heyecan\u0131)<\/li> <li><strong>Temmuz 2025<\/strong>: 15,10 $ (sekt\u00f6r genelinde biyotek geri \u00e7ekilmesi)<\/li> <li><strong>A\u011fustos 2025<\/strong>: 17,71 $ (mevcut toparlanma a\u015famas\u0131)<\/li> <\/ul> <p>Volatilitenin sebebi nedir? Bu rastgele bir g\u00fcr\u00fclt\u00fc de\u011fil\u2014klinik a\u015famadaki biyotek yat\u0131r\u0131m\u0131n\u0131n do\u011fas\u0131 bu. Her %10-20 hareket belirli tetikleyicilere kar\u015f\u0131l\u0131k geldi:<\/p> <ul> <li>D\u00fczenleyici onaylar %15-25 s\u0131\u00e7ramalar yarat\u0131yor<\/li> <li>Klinik deneme g\u00fcncellemeleri %8-12 hareketlere neden oluyor<\/li> <li>Sekt\u00f6r duyarl\u0131l\u0131\u011f\u0131 de\u011fi\u015fimleri g\u00fcnl\u00fck %5-8 dalgalanmalar s\u00fcr\u00fckl\u00fcyor<\/li> <\/ul> <p>Genel trend pozitif kal\u0131yor; hisse \u015eubat diplerinden yakla\u015f\u0131k %42 kazan\u00e7 sa\u011flad\u0131, biyotek sekt\u00f6r\u00fcndeki zorluklara ra\u011fmen.<\/p> <h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/h2> <p>Mevcut analist konsens\u00fcs\u00fc ve \u00fcr\u00fcn hatt\u0131 ilerlemesine dayanarak, bekleyebilecekleriniz:<\/p> <ul> <li><strong>2025 Y\u0131l Sonu<\/strong>: 35-45 $ aral\u0131\u011f\u0131 (3. \u00e7eyrek kazan\u00e7 s\u00fcrprizi ve \u00fcr\u00fcn hatt\u0131 g\u00fcncellemeleri ile) \u2192 <strong>G\u00dc\u00c7L\u00dc AL<\/strong><\/li> <li><strong>2026 Hedefi<\/strong>: 50-65 $ (ba\u015far\u0131l\u0131 BLA dosyas\u0131 ve potansiyel ortakl\u0131klar varsay\u0131m\u0131yla)<\/li> <li><strong>2028 Projeksiyonu<\/strong>: 75-100 $ (birden fazla onaylanm\u0131\u015f \u00fcr\u00fcn ve gelir art\u0131\u015f\u0131)<\/li> <li><strong>2030 Vizyonu<\/strong>: 120-150 $ (yerle\u015fik mRNA terap\u00f6tikleri lideri)<\/li> <\/ul> <p>Ortalama analist fiyat hedefi <strong>92,49 $<\/strong> seviyesinde olup, mevcut seviyelerden %400'\u00fcn \u00fczerinde potansiyel y\u00fckseli\u015f anlam\u0131na geliyor. 9 analistten 8'i \"G\u00fc\u00e7l\u00fc Al\" notunu koruyor; profesyonel duyarl\u0131l\u0131k olduk\u00e7a olumlu.<\/p> <h2>\u26a0\ufe0f Temel Riskler ve Pozitif Sinyaller<\/h2> <h3>Dikkate Al\u0131nmas\u0131 Gereken Riskler<\/h3> <ul> <li><strong>Klinik Deneme Ba\u015far\u0131s\u0131zl\u0131klar\u0131<\/strong>: Devam eden Faz 2 denemelerden olumsuz veri gelmesi halinde hisse %40-60 d\u00fc\u015febilir<\/li> <li><strong>D\u00fczenleyici Gecikmeler<\/strong>: FDA'n\u0131n KOSTAIVE BLA dosyas\u0131 kararlar\u0131 zaman \u00e7izelgesini geriye itebilir<\/li> <li><strong>Nakit T\u00fcketimi<\/strong>: 273,8 milyon $ nakit pozisyonuna ra\u011fmen y\u00fcksek Ar-Ge harcamalar\u0131 devam ediyor<\/li> <li><strong>Sekt\u00f6r Volatilitesi<\/strong>: Biyotek hisse senetleri genel piyasa duyarl\u0131l\u0131\u011f\u0131 de\u011fi\u015fimlerine kar\u015f\u0131 hassamd\u0131r<\/li> <\/ul> <h3>2025 \u0130\u00e7in Ye\u015fil I\u015f\u0131klar<\/h3> <ul> <li><strong>FDA Fast Track Tan\u0131m\u0131<\/strong>: ARCT-2304 grip a\u015f\u0131s\u0131 geli\u015ftirme s\u00fcrecinde h\u0131zland\u0131rma (<a href=\"https:\/\/arcturusrx.com\">\u015eirket Duyurusu<\/a>)<\/li> <li><strong>Avrupa Onay\u0131<\/strong>: KOSTAIVE COVID a\u015f\u0131s\u0131 AB'de onayland\u0131 (<a href=\"https:\/\/www.nasdaq.com\/press-release\/arcturus-therapeutics-announces-second-quarter-2025-financial-update-and-pipeline\">NASDAQ Raporu<\/a>)<\/li> <li><strong>Uzun Nakit Runway<\/strong>: 2028'e kadar finansman sa\u011flanmas\u0131 seyrelme riskini azalt\u0131yor<\/li> <li><strong>Sekt\u00f6r R\u00fczgarlar\u0131<\/strong>: Pandemi sonras\u0131 mRNA teknolojisi ana ak\u0131m kabul g\u00f6r\u00fcyor<\/li> <\/ul> <h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayan Bir T\u00fcccar Bug\u00fcn Ne Yapmal\u0131?<\/h2> <ol> <li><strong>K\u00fc\u00e7\u00fck Ba\u015flay\u0131n<\/strong>: Portf\u00f6y\u00fcn\u00fcz\u00fcn %3-5'inden fazlas\u0131n\u0131 y\u00fcksek volatiliteye sahip biyotek hisselerine ay\u0131rmay\u0131n<\/li> <li><strong>Dolar Maliyet Ortalamas\u0131<\/strong>: Birka\u00e7 hafta i\u00e7inde 500-1000 $ aras\u0131 al\u0131mlar yapmay\u0131 d\u00fc\u015f\u00fcn\u00fcn<\/li> <li><strong>Stop-Loss Belirleyin<\/strong>: Volatilite nedeniyle %15-20 stop-loss ile kendinizi koruyun<\/li> <li><strong>Tetikleyicileri \u0130zleyin<\/strong>: Kas\u0131m kazan\u00e7lar\u0131 ve klinik deneme g\u00fcncellemelerini takip edin<\/li> <\/ol> <p>Esprili bir yorum: \"ARCT ticareti yapmak, bir t\u0131bbi drama izlemek gibidir\u2014bekleyin s\u00fcrprizler, duygusal anlar ve reklam aralar\u0131nda kal\u0131rsan\u0131z potansiyel olarak hayat de\u011fi\u015ftiren sonu\u00e7lar!\"<\/p> <h2>\u2705 Arcturus Therapeutics Holdings Inc. (ARCT) Hisseleri Nas\u0131l Al\u0131n\u0131r - Ad\u0131m Ad\u0131m<\/h2> <table> <thead> <tr><th>Ad\u0131m<\/th><th>\u0130\u015flem<\/th><th>Neden \u00d6nemli<\/th><\/tr> <\/thead> <tbody> <tr><td>1<\/td><td>Bir Ticaret Platformu Se\u00e7in<\/td><td>NASDAQ eri\u015fimi ve makul komisyon \u00fccretleri sundu\u011fundan emin olun<\/td><\/tr> <tr><td>2<\/td><td>Hesap Fonlamas\u0131n\u0131 Tamamlay\u0131n<\/td><td>Kaybetmeyi g\u00f6ze alabilece\u011finiz bir miktarla ba\u015flay\u0131n<\/td><\/tr> <tr><td>3<\/td><td>\"ARCT\" Aramas\u0131 Yap\u0131n<\/td><td>\u015eirket ad\u0131 de\u011fil, tam borsa sembol\u00fcn\u00fc kullan\u0131n<\/td><\/tr> <tr><td>4<\/td><td>Emir T\u00fcr\u00fcn\u00fc Se\u00e7in<\/td><td>Giri\u015f fiyat\u0131n\u0131z\u0131 tam kontrol etmek i\u00e7in limit emirleri kullan\u0131n<\/td><\/tr> <tr><td>5<\/td><td>\u0130nceleyin ve Onaylay\u0131n<\/td><td>Sat\u0131n alma i\u015flemini tamamlamadan \u00f6nce emir detaylar\u0131n\u0131 iki kez kontrol edin<\/td><\/tr> <tr><td>6<\/td><td>Fiyat Uyar\u0131lar\u0131 Kurun<\/td><td>Gelecekteki kararlar i\u00e7in \u00f6nemli destek\/diren\u00e7 seviyelerini izleyin<\/td><\/tr> <tr><td>7<\/td><td>Yat\u0131r\u0131m Tezinizi Belgeleyin<\/td><td>Duygusal sat\u0131\u015flar\u0131 \u00f6nlemek i\u00e7in neden ald\u0131\u011f\u0131n\u0131z\u0131 yaz\u0131n<\/td><\/tr> <\/tbody> <\/table> <h2>\ud83d\udca1 Neden Pocket Option Yeni Yat\u0131r\u0131mc\u0131lar \u0130\u00e7in Uygun?<\/h2> <p>Biyotek yat\u0131r\u0131m\u0131na ad\u0131m atmak isteyenler i\u00e7in Pocket Option birka\u00e7 avantaj sunuyor:<\/p> <p><strong>Sadece 5 $ minimum depozito<\/strong> ile stratejilerinizi d\u00fc\u015f\u00fck riskle test edebilirsiniz. Platformun <strong>1 dakikal\u0131k KYC s\u00fcreci<\/strong> herhangi tek belge ile hemen ticarete ba\u015flaman\u0131z\u0131 sa\u011flar. Kripto, e-c\u00fczdanlar ve geleneksel bankac\u0131l\u0131k dahil <strong>100'den fazla para \u00e7ekme y\u00f6ntemi<\/strong> ile karlar\u0131n\u0131za eri\u015fim son derece kolayd\u0131r.<\/p> <p>Kullan\u0131c\u0131 dostu aray\u00fcz, ARCT gibi karma\u015f\u0131k biyotek hisselerinde yeni ba\u015flayanlar i\u00e7in gezinmeyi kolayla\u015ft\u0131r\u0131rken, geli\u015fmi\u015f grafik ara\u00e7lar\u0131 deneyimli yat\u0131r\u0131mc\u0131lar\u0131n ihtiya\u00e7lar\u0131n\u0131 kar\u015f\u0131lar.<\/p> <h2>\ud83c\udf0d 2025'te Arcturus: mRNA Yenilik Lideri<\/h2> <p>Arcturus Therapeutics, hastal\u0131klar\u0131n tedavisinde devrim yaratabilecek kendi kendini \u00e7o\u011faltan mRNA teknolojisinde \u00f6nc\u00fc konumda. \u015eirketin mevcut oda\u011f\u0131 bula\u015f\u0131c\u0131 hastal\u0131k a\u015f\u0131lar\u0131 ve karaci\u011fer ile solunum nadir hastal\u0131klar\u0131 tedavileridir.<\/p> <p>KOSTAIVE'nin (ilk kendi kendini \u00e7o\u011faltan mRNA COVID-19 a\u015f\u0131s\u0131) Avrupa onay\u0131 ve pandemi gribi a\u015f\u0131s\u0131 i\u00e7in FDA Fast Track tan\u0131m\u0131 ile Arcturus, platformunun d\u00fczenleyici onay\u0131n\u0131 kan\u0131tlam\u0131\u015ft\u0131r.<\/p> <p><strong>\u0130lgin\u00e7 Bilgi<\/strong>: 2025 y\u0131l\u0131nda Arcturus bilim insanlar\u0131, mRNA platformlar\u0131n\u0131n geleneksel mRNA a\u015f\u0131lar\u0131na k\u0131yasla a\u015f\u0131 dozaj gereksinimlerini %80'e kadar azaltabilece\u011fini ke\u015ffettiler\u2014bu, geli\u015fmekte olan \u00fclkelerde a\u015f\u0131 da\u011f\u0131t\u0131m\u0131n\u0131 devrim niteli\u011finde de\u011fi\u015ftirebilir.<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 G\u00fcncel Hisse Performans\u0131 ve \u00d6nemli Tarihler<\/h2>\n<p>26 A\u011fustos 2025 itibar\u0131yla, Arcturus Therapeutics Holdings Inc. (ARCT) NASDAQ borsas\u0131nda <strong>17,71 $<\/strong> fiyatla i\u015flem g\u00f6r\u00fcyor. Bu fiyat, \u015firketin son geli\u015fmeleri ve gelecekteki potansiyeli g\u00f6z \u00f6n\u00fcne al\u0131nd\u0131\u011f\u0131nda ilgi \u00e7ekici bir giri\u015f noktas\u0131 sunuyor.<\/p>\n<p><strong>Takviminize not edin: 6 Kas\u0131m 2025 kesinlikle kritik.<\/strong> Bu tarihte Arcturus, 3. \u00e7eyrek kazan\u00e7 raporunu a\u00e7\u0131klayacak. Tarihsel olarak, bu \u00e7eyreklik g\u00fcncellemeler \u00f6nemli fiyat hareketlerine neden olmu\u015f ve yat\u0131r\u0131m tezinizin kaderini belirleyebilir.<\/p>\n<h3>Kazan\u00e7 Raporlar\u0131 ARCT Hissesini Nas\u0131l Hareket Ettirir<\/h3>\n<p>Son tarihleri incelemek zamanlaman\u0131n neden \u00f6nemli oldu\u011funu g\u00f6steriyor:<\/p>\n<p><strong>\u015eubat 2025 4. \u00c7eyrek Kazan\u00e7lar\u0131<\/strong>: Hisse, olumlu klinik deneme g\u00fcncellemeleri sonras\u0131 %15 y\u00fckseldi; finansal sonu\u00e7lar kar\u0131\u015f\u0131k olsa da yat\u0131r\u0131mc\u0131lar k\u0131sa vadeli gelir d\u00fc\u015f\u00fc\u015flerinden \u00e7ok \u00fcr\u00fcn hatt\u0131ndaki ilerlemeye odakland\u0131.<\/p>\n<p><strong>A\u011fustos 2025 2. \u00c7eyrek Kazan\u00e7lar\u0131<\/strong>: Hisseler ba\u015flang\u0131\u00e7ta gelir endi\u015feleriyle %8 d\u00fc\u015ft\u00fc ancak analistlerin 2028&#8217;e kadar uzayan nakit runway&#8217;i vurgulamas\u0131yla birka\u00e7 g\u00fcn i\u00e7inde toparland\u0131.<\/p>\n<p><strong>May\u0131s 2025 Kurumsal G\u00fcncelleme<\/strong>: Grip a\u015f\u0131 adaylar\u0131 i\u00e7in FDA Fast Track tan\u0131m\u0131 duyurusu sonras\u0131 %22 art\u0131\u015f ya\u015fand\u0131.<\/p>\n<p>Desen a\u00e7\u0131k: ARCT, hem finansal sonu\u00e7lara hem de klinik\/d\u00fczenleyici haberlere dramatik \u015fekilde tepki veriyor. Ak\u0131ll\u0131 yat\u0131r\u0131mc\u0131lar, kazan\u00e7 sonras\u0131 d\u00fc\u015f\u00fc\u015fleri pozisyon a\u00e7mak i\u00e7in f\u0131rsat olarak izliyor.<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/tr\/register\/\" class=\"po-cta-green\">Ticarete Ba\u015fla\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udcca 6 Ayl\u0131k Fiyat Yolculu\u011fu: Ama\u00e7l\u0131 Bir Rollercoaster<\/h2>\n<p>Arcturus hisseleri son alt\u0131 ayda \u00e7\u0131lg\u0131n ama nihayetinde \u00f6d\u00fcllendirici bir seyir izledi:<\/p>\n<ul>\n<li><strong>\u015eubat 2025<\/strong>: 12,50 $ (tatil sonras\u0131 konsolidasyon)<\/li>\n<li><strong>Mart 2025<\/strong>: 14,80 $ (KOSTAIVE COVID a\u015f\u0131s\u0131n\u0131n Avrupa onay\u0131)<\/li>\n<li><strong>May\u0131s 2025<\/strong>: 16,25 $ (FDA Fast Track tan\u0131m\u0131 heyecan\u0131)<\/li>\n<li><strong>Temmuz 2025<\/strong>: 15,10 $ (sekt\u00f6r genelinde biyotek geri \u00e7ekilmesi)<\/li>\n<li><strong>A\u011fustos 2025<\/strong>: 17,71 $ (mevcut toparlanma a\u015famas\u0131)<\/li>\n<\/ul>\n<p>Volatilitenin sebebi nedir? Bu rastgele bir g\u00fcr\u00fclt\u00fc de\u011fil\u2014klinik a\u015famadaki biyotek yat\u0131r\u0131m\u0131n\u0131n do\u011fas\u0131 bu. Her %10-20 hareket belirli tetikleyicilere kar\u015f\u0131l\u0131k geldi:<\/p>\n<ul>\n<li>D\u00fczenleyici onaylar %15-25 s\u0131\u00e7ramalar yarat\u0131yor<\/li>\n<li>Klinik deneme g\u00fcncellemeleri %8-12 hareketlere neden oluyor<\/li>\n<li>Sekt\u00f6r duyarl\u0131l\u0131\u011f\u0131 de\u011fi\u015fimleri g\u00fcnl\u00fck %5-8 dalgalanmalar s\u00fcr\u00fckl\u00fcyor<\/li>\n<\/ul>\n<p>Genel trend pozitif kal\u0131yor; hisse \u015eubat diplerinden yakla\u015f\u0131k %42 kazan\u00e7 sa\u011flad\u0131, biyotek sekt\u00f6r\u00fcndeki zorluklara ra\u011fmen.<\/p>\n<h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/h2>\n<p>Mevcut analist konsens\u00fcs\u00fc ve \u00fcr\u00fcn hatt\u0131 ilerlemesine dayanarak, bekleyebilecekleriniz:<\/p>\n<ul>\n<li><strong>2025 Y\u0131l Sonu<\/strong>: 35-45 $ aral\u0131\u011f\u0131 (3. \u00e7eyrek kazan\u00e7 s\u00fcrprizi ve \u00fcr\u00fcn hatt\u0131 g\u00fcncellemeleri ile) \u2192 <strong>G\u00dc\u00c7L\u00dc AL<\/strong><\/li>\n<li><strong>2026 Hedefi<\/strong>: 50-65 $ (ba\u015far\u0131l\u0131 BLA dosyas\u0131 ve potansiyel ortakl\u0131klar varsay\u0131m\u0131yla)<\/li>\n<li><strong>2028 Projeksiyonu<\/strong>: 75-100 $ (birden fazla onaylanm\u0131\u015f \u00fcr\u00fcn ve gelir art\u0131\u015f\u0131)<\/li>\n<li><strong>2030 Vizyonu<\/strong>: 120-150 $ (yerle\u015fik mRNA terap\u00f6tikleri lideri)<\/li>\n<\/ul>\n<p>Ortalama analist fiyat hedefi <strong>92,49 $<\/strong> seviyesinde olup, mevcut seviyelerden %400&#8217;\u00fcn \u00fczerinde potansiyel y\u00fckseli\u015f anlam\u0131na geliyor. 9 analistten 8&#8217;i &#8220;G\u00fc\u00e7l\u00fc Al&#8221; notunu koruyor; profesyonel duyarl\u0131l\u0131k olduk\u00e7a olumlu.<\/p>\n<h2>\u26a0\ufe0f Temel Riskler ve Pozitif Sinyaller<\/h2>\n<h3>Dikkate Al\u0131nmas\u0131 Gereken Riskler<\/h3>\n<ul>\n<li><strong>Klinik Deneme Ba\u015far\u0131s\u0131zl\u0131klar\u0131<\/strong>: Devam eden Faz 2 denemelerden olumsuz veri gelmesi halinde hisse %40-60 d\u00fc\u015febilir<\/li>\n<li><strong>D\u00fczenleyici Gecikmeler<\/strong>: FDA&#8217;n\u0131n KOSTAIVE BLA dosyas\u0131 kararlar\u0131 zaman \u00e7izelgesini geriye itebilir<\/li>\n<li><strong>Nakit T\u00fcketimi<\/strong>: 273,8 milyon $ nakit pozisyonuna ra\u011fmen y\u00fcksek Ar-Ge harcamalar\u0131 devam ediyor<\/li>\n<li><strong>Sekt\u00f6r Volatilitesi<\/strong>: Biyotek hisse senetleri genel piyasa duyarl\u0131l\u0131\u011f\u0131 de\u011fi\u015fimlerine kar\u015f\u0131 hassamd\u0131r<\/li>\n<\/ul>\n<h3>2025 \u0130\u00e7in Ye\u015fil I\u015f\u0131klar<\/h3>\n<ul>\n<li><strong>FDA Fast Track Tan\u0131m\u0131<\/strong>: ARCT-2304 grip a\u015f\u0131s\u0131 geli\u015ftirme s\u00fcrecinde h\u0131zland\u0131rma (<a href=\"https:\/\/arcturusrx.com\">\u015eirket Duyurusu<\/a>)<\/li>\n<li><strong>Avrupa Onay\u0131<\/strong>: KOSTAIVE COVID a\u015f\u0131s\u0131 AB&#8217;de onayland\u0131 (<a href=\"https:\/\/www.nasdaq.com\/press-release\/arcturus-therapeutics-announces-second-quarter-2025-financial-update-and-pipeline\">NASDAQ Raporu<\/a>)<\/li>\n<li><strong>Uzun Nakit Runway<\/strong>: 2028&#8217;e kadar finansman sa\u011flanmas\u0131 seyrelme riskini azalt\u0131yor<\/li>\n<li><strong>Sekt\u00f6r R\u00fczgarlar\u0131<\/strong>: Pandemi sonras\u0131 mRNA teknolojisi ana ak\u0131m kabul g\u00f6r\u00fcyor<\/li>\n<\/ul>\n<h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayan Bir T\u00fcccar Bug\u00fcn Ne Yapmal\u0131?<\/h2>\n<ol>\n<li><strong>K\u00fc\u00e7\u00fck Ba\u015flay\u0131n<\/strong>: Portf\u00f6y\u00fcn\u00fcz\u00fcn %3-5&#8217;inden fazlas\u0131n\u0131 y\u00fcksek volatiliteye sahip biyotek hisselerine ay\u0131rmay\u0131n<\/li>\n<li><strong>Dolar Maliyet Ortalamas\u0131<\/strong>: Birka\u00e7 hafta i\u00e7inde 500-1000 $ aras\u0131 al\u0131mlar yapmay\u0131 d\u00fc\u015f\u00fcn\u00fcn<\/li>\n<li><strong>Stop-Loss Belirleyin<\/strong>: Volatilite nedeniyle %15-20 stop-loss ile kendinizi koruyun<\/li>\n<li><strong>Tetikleyicileri \u0130zleyin<\/strong>: Kas\u0131m kazan\u00e7lar\u0131 ve klinik deneme g\u00fcncellemelerini takip edin<\/li>\n<\/ol>\n<p>Esprili bir yorum: &#8220;ARCT ticareti yapmak, bir t\u0131bbi drama izlemek gibidir\u2014bekleyin s\u00fcrprizler, duygusal anlar ve reklam aralar\u0131nda kal\u0131rsan\u0131z potansiyel olarak hayat de\u011fi\u015ftiren sonu\u00e7lar!&#8221;<\/p>\n<h2>\u2705 Arcturus Therapeutics Holdings Inc. (ARCT) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Ad\u0131m Ad\u0131m<\/h2>\n<table>\n<thead>\n<tr>\n<th>Ad\u0131m<\/th>\n<th>\u0130\u015flem<\/th>\n<th>Neden \u00d6nemli<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Bir Ticaret Platformu Se\u00e7in<\/td>\n<td>NASDAQ eri\u015fimi ve makul komisyon \u00fccretleri sundu\u011fundan emin olun<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Hesap Fonlamas\u0131n\u0131 Tamamlay\u0131n<\/td>\n<td>Kaybetmeyi g\u00f6ze alabilece\u011finiz bir miktarla ba\u015flay\u0131n<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>&#8220;ARCT&#8221; Aramas\u0131 Yap\u0131n<\/td>\n<td>\u015eirket ad\u0131 de\u011fil, tam borsa sembol\u00fcn\u00fc kullan\u0131n<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>Emir T\u00fcr\u00fcn\u00fc Se\u00e7in<\/td>\n<td>Giri\u015f fiyat\u0131n\u0131z\u0131 tam kontrol etmek i\u00e7in limit emirleri kullan\u0131n<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>\u0130nceleyin ve Onaylay\u0131n<\/td>\n<td>Sat\u0131n alma i\u015flemini tamamlamadan \u00f6nce emir detaylar\u0131n\u0131 iki kez kontrol edin<\/td>\n<\/tr>\n<tr>\n<td>6<\/td>\n<td>Fiyat Uyar\u0131lar\u0131 Kurun<\/td>\n<td>Gelecekteki kararlar i\u00e7in \u00f6nemli destek\/diren\u00e7 seviyelerini izleyin<\/td>\n<\/tr>\n<tr>\n<td>7<\/td>\n<td>Yat\u0131r\u0131m Tezinizi Belgeleyin<\/td>\n<td>Duygusal sat\u0131\u015flar\u0131 \u00f6nlemek i\u00e7in neden ald\u0131\u011f\u0131n\u0131z\u0131 yaz\u0131n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83d\udca1 Neden Pocket Option Yeni Yat\u0131r\u0131mc\u0131lar \u0130\u00e7in Uygun?<\/h2>\n<p>Biyotek yat\u0131r\u0131m\u0131na ad\u0131m atmak isteyenler i\u00e7in Pocket Option birka\u00e7 avantaj sunuyor:<\/p>\n<p><strong>Sadece 5 $ minimum depozito<\/strong> ile stratejilerinizi d\u00fc\u015f\u00fck riskle test edebilirsiniz. Platformun <strong>1 dakikal\u0131k KYC s\u00fcreci<\/strong> herhangi tek belge ile hemen ticarete ba\u015flaman\u0131z\u0131 sa\u011flar. Kripto, e-c\u00fczdanlar ve geleneksel bankac\u0131l\u0131k dahil <strong>100&#8217;den fazla para \u00e7ekme y\u00f6ntemi<\/strong> ile karlar\u0131n\u0131za eri\u015fim son derece kolayd\u0131r.<\/p>\n<p>Kullan\u0131c\u0131 dostu aray\u00fcz, ARCT gibi karma\u015f\u0131k biyotek hisselerinde yeni ba\u015flayanlar i\u00e7in gezinmeyi kolayla\u015ft\u0131r\u0131rken, geli\u015fmi\u015f grafik ara\u00e7lar\u0131 deneyimli yat\u0131r\u0131mc\u0131lar\u0131n ihtiya\u00e7lar\u0131n\u0131 kar\u015f\u0131lar.<\/p>\n<h2>\ud83c\udf0d 2025&#8217;te Arcturus: mRNA Yenilik Lideri<\/h2>\n<p>Arcturus Therapeutics, hastal\u0131klar\u0131n tedavisinde devrim yaratabilecek kendi kendini \u00e7o\u011faltan mRNA teknolojisinde \u00f6nc\u00fc konumda. \u015eirketin mevcut oda\u011f\u0131 bula\u015f\u0131c\u0131 hastal\u0131k a\u015f\u0131lar\u0131 ve karaci\u011fer ile solunum nadir hastal\u0131klar\u0131 tedavileridir.<\/p>\n<p>KOSTAIVE&#8217;nin (ilk kendi kendini \u00e7o\u011faltan mRNA COVID-19 a\u015f\u0131s\u0131) Avrupa onay\u0131 ve pandemi gribi a\u015f\u0131s\u0131 i\u00e7in FDA Fast Track tan\u0131m\u0131 ile Arcturus, platformunun d\u00fczenleyici onay\u0131n\u0131 kan\u0131tlam\u0131\u015ft\u0131r.<\/p>\n<p><strong>\u0130lgin\u00e7 Bilgi<\/strong>: 2025 y\u0131l\u0131nda Arcturus bilim insanlar\u0131, mRNA platformlar\u0131n\u0131n geleneksel mRNA a\u015f\u0131lar\u0131na k\u0131yasla a\u015f\u0131 dozaj gereksinimlerini %80&#8217;e kadar azaltabilece\u011fini ke\u015ffettiler\u2014bu, geli\u015fmekte olan \u00fclkelerde a\u015f\u0131 da\u011f\u0131t\u0131m\u0131n\u0131 devrim niteli\u011finde de\u011fi\u015ftirebilir.<\/p>\n"},"faq":[{"question":"Arcturus Therapeutics hisseleri nereden al\u0131nabilir?","answer":"ARCT hisseleri NASDAQ borsas\u0131nda i\u015flem g\u00f6rmektedir. G\u00fcvenilir bir arac\u0131 kurum veya online ticaret platformu \u00fczerinden sat\u0131n alabilirsiniz."},{"question":"Arcturus Therapeutics'in gelecekteki fiyat beklentisi nedir?","answer":"Analistlerin ortalama fiyat hedefi 92,49 $ civar\u0131ndad\u0131r ve 2025-2030 aras\u0131nda \u00f6nemli bir b\u00fcy\u00fcme potansiyeli \u00f6ng\u00f6r\u00fclmektedir."},{"question":"Yat\u0131r\u0131m yaparken hangi riskler g\u00f6z \u00f6n\u00fcnde bulundurulmal\u0131?","answer":"Klinik deneme ba\u015far\u0131s\u0131zl\u0131klar\u0131, d\u00fczenleyici gecikmeler, y\u00fcksek nakit t\u00fcketimi ve sekt\u00f6r volatilitesi ba\u015fl\u0131ca risklerdir."},{"question":"Yeni ba\u015flayanlar ARCT hisselerine nas\u0131l yat\u0131r\u0131m yapmal\u0131?","answer":"Portf\u00f6y\u00fcn %3-5'i ile k\u00fc\u00e7\u00fck ba\u015flay\u0131p, dolar maliyet ortalamas\u0131 yaparak, stop-loss kullanarak ve \u00f6nemli haberleri takip ederek yat\u0131r\u0131m yapmalar\u0131 \u00f6nerilir."},{"question":"Pocket Option yeni yat\u0131r\u0131mc\u0131lar i\u00e7in neden uygundur?","answer":"D\u00fc\u015f\u00fck minimum depozito, h\u0131zl\u0131 KYC s\u00fcreci, \u00e7ok say\u0131da para \u00e7ekme y\u00f6ntemi ve kullan\u0131c\u0131 dostu aray\u00fcz\u00fc ile yeni ba\u015flayanlar i\u00e7in idealdir."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"Arcturus Therapeutics hisseleri nereden al\u0131nabilir?","answer":"ARCT hisseleri NASDAQ borsas\u0131nda i\u015flem g\u00f6rmektedir. G\u00fcvenilir bir arac\u0131 kurum veya online ticaret platformu \u00fczerinden sat\u0131n alabilirsiniz."},{"question":"Arcturus Therapeutics'in gelecekteki fiyat beklentisi nedir?","answer":"Analistlerin ortalama fiyat hedefi 92,49 $ civar\u0131ndad\u0131r ve 2025-2030 aras\u0131nda \u00f6nemli bir b\u00fcy\u00fcme potansiyeli \u00f6ng\u00f6r\u00fclmektedir."},{"question":"Yat\u0131r\u0131m yaparken hangi riskler g\u00f6z \u00f6n\u00fcnde bulundurulmal\u0131?","answer":"Klinik deneme ba\u015far\u0131s\u0131zl\u0131klar\u0131, d\u00fczenleyici gecikmeler, y\u00fcksek nakit t\u00fcketimi ve sekt\u00f6r volatilitesi ba\u015fl\u0131ca risklerdir."},{"question":"Yeni ba\u015flayanlar ARCT hisselerine nas\u0131l yat\u0131r\u0131m yapmal\u0131?","answer":"Portf\u00f6y\u00fcn %3-5'i ile k\u00fc\u00e7\u00fck ba\u015flay\u0131p, dolar maliyet ortalamas\u0131 yaparak, stop-loss kullanarak ve \u00f6nemli haberleri takip ederek yat\u0131r\u0131m yapmalar\u0131 \u00f6nerilir."},{"question":"Pocket Option yeni yat\u0131r\u0131mc\u0131lar i\u00e7in neden uygundur?","answer":"D\u00fc\u015f\u00fck minimum depozito, h\u0131zl\u0131 KYC s\u00fcreci, \u00e7ok say\u0131da para \u00e7ekme y\u00f6ntemi ve kullan\u0131c\u0131 dostu aray\u00fcz\u00fc ile yeni ba\u015flayanlar i\u00e7in idealdir."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Arcturus Therapeutics Holdings Inc. (ARCT) Hisseleri Nas\u0131l Al\u0131n\u0131r - Arcturus Therapeutics Holdings Inc. (ARCT) Hisse Senedi Yat\u0131r\u0131m\u0131<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-arcturus-therapeutics-holdings\/\" \/>\n<meta property=\"og:locale\" content=\"tr_TR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Arcturus Therapeutics Holdings Inc. (ARCT) Hisseleri Nas\u0131l Al\u0131n\u0131r - Arcturus Therapeutics Holdings Inc. (ARCT) Hisse Senedi Yat\u0131r\u0131m\u0131\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-arcturus-therapeutics-holdings\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-26T07:28:15+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Yazan:\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-arcturus-therapeutics-holdings\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-arcturus-therapeutics-holdings\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"Arcturus Therapeutics Holdings Inc. (ARCT) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Arcturus Therapeutics Holdings Inc. (ARCT) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"datePublished\":\"2025-08-26T07:28:15+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-arcturus-therapeutics-holdings\/\"},\"wordCount\":23,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-arcturus-therapeutics-holdings\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals12.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-arcturus-therapeutics-holdings\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-arcturus-therapeutics-holdings\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-arcturus-therapeutics-holdings\/\",\"name\":\"Arcturus Therapeutics Holdings Inc. (ARCT) Hisseleri Nas\u0131l Al\u0131n\u0131r - Arcturus Therapeutics Holdings Inc. (ARCT) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-arcturus-therapeutics-holdings\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-arcturus-therapeutics-holdings\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals12.webp\",\"datePublished\":\"2025-08-26T07:28:15+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-arcturus-therapeutics-holdings\/#breadcrumb\"},\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-arcturus-therapeutics-holdings\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-arcturus-therapeutics-holdings\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals12.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals12.webp\",\"width\":1024,\"height\":576},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-arcturus-therapeutics-holdings\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/tr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Arcturus Therapeutics Holdings Inc. (ARCT) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Arcturus Therapeutics Holdings Inc. (ARCT) Hisse Senedi Yat\u0131r\u0131m\u0131\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"tr\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Arcturus Therapeutics Holdings Inc. (ARCT) Hisseleri Nas\u0131l Al\u0131n\u0131r - Arcturus Therapeutics Holdings Inc. (ARCT) Hisse Senedi Yat\u0131r\u0131m\u0131","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-arcturus-therapeutics-holdings\/","og_locale":"tr_TR","og_type":"article","og_title":"Arcturus Therapeutics Holdings Inc. (ARCT) Hisseleri Nas\u0131l Al\u0131n\u0131r - Arcturus Therapeutics Holdings Inc. (ARCT) Hisse Senedi Yat\u0131r\u0131m\u0131","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-arcturus-therapeutics-holdings\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-26T07:28:15+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Yazan:":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-arcturus-therapeutics-holdings\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-arcturus-therapeutics-holdings\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"Arcturus Therapeutics Holdings Inc. (ARCT) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Arcturus Therapeutics Holdings Inc. (ARCT) Hisse Senedi Yat\u0131r\u0131m\u0131","datePublished":"2025-08-26T07:28:15+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-arcturus-therapeutics-holdings\/"},"wordCount":23,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-arcturus-therapeutics-holdings\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals12.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"tr","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-arcturus-therapeutics-holdings\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-arcturus-therapeutics-holdings\/","url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-arcturus-therapeutics-holdings\/","name":"Arcturus Therapeutics Holdings Inc. (ARCT) Hisseleri Nas\u0131l Al\u0131n\u0131r - Arcturus Therapeutics Holdings Inc. (ARCT) Hisse Senedi Yat\u0131r\u0131m\u0131","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-arcturus-therapeutics-holdings\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-arcturus-therapeutics-holdings\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals12.webp","datePublished":"2025-08-26T07:28:15+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-arcturus-therapeutics-holdings\/#breadcrumb"},"inLanguage":"tr","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-arcturus-therapeutics-holdings\/"]}]},{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-arcturus-therapeutics-holdings\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals12.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals12.webp","width":1024,"height":576},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-arcturus-therapeutics-holdings\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/tr\/"},{"@type":"ListItem","position":2,"name":"Arcturus Therapeutics Holdings Inc. (ARCT) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Arcturus Therapeutics Holdings Inc. (ARCT) Hisse Senedi Yat\u0131r\u0131m\u0131"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/tr\/#website","url":"https:\/\/pocketoption.com\/blog\/tr\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"tr"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"tr_TR","wpml_translations":{"vt_VT":{"locale":"vt_VT","id":352257,"slug":"how-to-buy-arcturus-therapeutics-holdings","post_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Arcturus Therapeutics Holdings Inc. (ARCT) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Arcturus Therapeutics Holdings Inc. (ARCT)","href":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-arcturus-therapeutics-holdings\/"},"pt_AA":{"locale":"pt_AA","id":352262,"slug":"how-to-buy-arcturus-therapeutics-holdings","post_title":"Como comprar a\u00e7\u00f5es da Arcturus Therapeutics Holdings Inc. (ARCT) - Investimento em a\u00e7\u00f5es da Arcturus Therapeutics Holdings Inc. (ARCT)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-arcturus-therapeutics-holdings\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/352261","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/comments?post=352261"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/352261\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media\/334090"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media?parent=352261"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/categories?post=352261"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/tags?post=352261"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}